Search research articles
Contact Us
Filters
Showing results (181-190 of 193) with videos related to
Page
of 20
Sort By:
Korean Circulation Journal
|
February 7, 2022
Prasugrel-based De-Escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With STEMI
You-Jeong Ki, Bong Ki Lee, Kyung Woo Park, et al.
Lancet (London, England)
|
February 3, 2026
Dual antiplatelet therapy after percutaneous coronary intervention according to bleeding risk (HOST-BR): an open-label, multicentre, randomised clinical trial
Jeehoon Kang, Kyung Woo Park, Jung-Kyu Han, et al.
American Heart Journal
|
April 30, 2013
Randomized trial comparing the efficacy between different types of paclitaxel-eluting stents: the comparison of efficacy between COroflex PLEASe ANd Taxus stent (ECO-PLEASANT) randomized controlled trial
Jae-Bin Seo, Si-Hyuck Kang, Seung-Ho Hur, et al.
Trials
|
September 17, 2015
Harmonizing Optimal Strategy for Treatment of coronary artery diseases--comparison of REDUCtion of prasugrEl dose or POLYmer TECHnology in ACS patients (HOST-REDUCE-POLYTECH-ACS RCT): study protocol for a randomized controlled trial
Joo Myung Lee, Ji-Hyun Jung, Kyung Woo Park, et al.
Journal of the American College of Cardiology
|
October 25, 2011
Everolimus-eluting versus sirolimus-eluting stents in patients undergoing percutaneous coronary intervention: the EXCELLENT (Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting) randomized trial
Kyung Woo Park, In-Ho Chae, Do-Sun Lim, et al.
The American Journal of Cardiology
|
September 14, 2014
Three-year patient-related and stent-related outcomes of second-generation everolimus-eluting Xience V stents versus zotarolimus-eluting resolute stents in real-world practice (from the Multicenter Prospective EXCELLENT and RESOLUTE-Korea Registries)
Joo Myung Lee, Kyung Woo Park, Jung-Kyu Han, et al.
JACC. Cardiovascular Interventions
|
May 22, 2010
Paclitaxel- versus sirolimus-eluting stents for treatment of ST-segment elevation myocardial infarction: with analyses for diabetic and nondiabetic subpopulation
Youngjin Cho, Han-Mo Yang, Kyung-Woo Park, et al.
Korean Circulation Journal
|
November 27, 2024
Sex Differences in Procedural Characteristics and Clinical Outcomes Among Patients Undergoing Bifurcation PCI
Hyun Jin Ahn, Francesco Bruno, Jeehoon Kang, et al.
JACC. Asia
|
December 15, 2022
Impact of Clinical and Lesion Features on Outcomes After Percutaneous Coronary Intervention in Bifurcation Lesions
Jeehoon Kang, Francesco Bruno, Tae-Min Rhee, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
September 5, 2023
Impact of diabetes on long-term outcomes of bifurcation percutaneous coronary intervention. An analysis from the BIFURCAT registry
Francesco Bruno, Jeehoon Kang, Edoardo Elia, et al.
Page
of 20
Search research articles
Search
Showing results (181-190 of 193) with videos related to
Sort By:
Page
of 20
Korean Circulation Journal
|
February 7, 2022
Prasugrel-based De-Escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With STEMI
You-Jeong Ki, Bong Ki Lee, Kyung Woo Park, et al.
Lancet (London, England)
|
February 3, 2026
Dual antiplatelet therapy after percutaneous coronary intervention according to bleeding risk (HOST-BR): an open-label, multicentre, randomised clinical trial
Jeehoon Kang, Kyung Woo Park, Jung-Kyu Han, et al.
American Heart Journal
|
April 30, 2013
Randomized trial comparing the efficacy between different types of paclitaxel-eluting stents: the comparison of efficacy between COroflex PLEASe ANd Taxus stent (ECO-PLEASANT) randomized controlled trial
Jae-Bin Seo, Si-Hyuck Kang, Seung-Ho Hur, et al.
Trials
|
September 17, 2015
Harmonizing Optimal Strategy for Treatment of coronary artery diseases--comparison of REDUCtion of prasugrEl dose or POLYmer TECHnology in ACS patients (HOST-REDUCE-POLYTECH-ACS RCT): study protocol for a randomized controlled trial
Joo Myung Lee, Ji-Hyun Jung, Kyung Woo Park, et al.
Journal of the American College of Cardiology
|
October 25, 2011
Everolimus-eluting versus sirolimus-eluting stents in patients undergoing percutaneous coronary intervention: the EXCELLENT (Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting) randomized trial
Kyung Woo Park, In-Ho Chae, Do-Sun Lim, et al.
The American Journal of Cardiology
|
September 14, 2014
Three-year patient-related and stent-related outcomes of second-generation everolimus-eluting Xience V stents versus zotarolimus-eluting resolute stents in real-world practice (from the Multicenter Prospective EXCELLENT and RESOLUTE-Korea Registries)
Joo Myung Lee, Kyung Woo Park, Jung-Kyu Han, et al.
JACC. Cardiovascular Interventions
|
May 22, 2010
Paclitaxel- versus sirolimus-eluting stents for treatment of ST-segment elevation myocardial infarction: with analyses for diabetic and nondiabetic subpopulation
Youngjin Cho, Han-Mo Yang, Kyung-Woo Park, et al.
Korean Circulation Journal
|
November 27, 2024
Sex Differences in Procedural Characteristics and Clinical Outcomes Among Patients Undergoing Bifurcation PCI
Hyun Jin Ahn, Francesco Bruno, Jeehoon Kang, et al.
JACC. Asia
|
December 15, 2022
Impact of Clinical and Lesion Features on Outcomes After Percutaneous Coronary Intervention in Bifurcation Lesions
Jeehoon Kang, Francesco Bruno, Tae-Min Rhee, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
September 5, 2023
Impact of diabetes on long-term outcomes of bifurcation percutaneous coronary intervention. An analysis from the BIFURCAT registry
Francesco Bruno, Jeehoon Kang, Edoardo Elia, et al.
Page
of 20